A Novel Mitochondrial Targeted Compound Phosundoxin Showing Potent Antifungal Activity against Common Clinical

Shu Zhang1,2, Yuanyuan Geng1,2, Bin Wei1

  • 1National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.

Insights

Phosundoxin shows broad-spectrum antifungal activity against pathogenic fungi, including azole-resistant strains. This novel drug targets mitochondria and exhibits low toxicity, offering potential for treating fungal infections.

Area of Science:

  • Mycology
  • Pharmacology
  • Biochemistry

Background:

  • Rising antifungal drug resistance necessitates novel therapeutic agents.
  • Phosundoxin is a novel biphenyl aliphatic amide targeting mitochondria via a TPP-targeting strategy.

Purpose of the Study:

  • To evaluate the antifungal activity and mechanism of action of phosundoxin.
  • To assess the efficacy of phosundoxin against a panel of pathogenic fungi, including azole-resistant isolates.
  • To determine the toxicity profile of phosundoxin.

Main Methods:

  • Antifungal susceptibility testing on 158 fungal strains.
  • Comparison with traditional azole drugs.
  • Transcriptome analysis and pathway enrichment analysis (GO, KEGG) on azole-resistant *Candida albicans*.
  • Acute oral and percutaneous toxicity studies in rats.

Main Results:

  • Phosundoxin demonstrated broad-spectrum antifungal activity (2-16 mg/L) against yeast-like and filamentous fungi.
  • Effective against azole-resistant *Candida albicans* isolates with consistent Minimum Inhibitory Concentrations (MICs).
  • Transcriptome analysis revealed 554 differentially expressed genes (DEGs) and indicated mitochondrial respiratory chain dysfunction.
  • Phosundoxin exhibited mild toxicity in rats, with an LD50 > 5000 mg/kg.

Conclusions:

  • Phosundoxin is a promising antifungal agent with broad-spectrum activity and a novel mechanism targeting mitochondrial function.
  • It is effective against azole-resistant fungal strains, suggesting potential for overcoming existing resistance mechanisms.
  • Phosundoxin possesses a favorable safety profile, supporting its development for treating common fungal infections.